Suheung Co., Ltd. (008490.KS)
KRW 12880.0
(-1.68%)
KRW 12880.0
(-1.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 429.14 Billion KRW | 16.72% |
| 2022 | 367.65 Billion KRW | 16.1% |
| 2021 | 316.66 Billion KRW | 2.03% |
| 2020 | 310.35 Billion KRW | 3.83% |
| 2019 | 298.91 Billion KRW | 14.87% |
| 2018 | 260.21 Billion KRW | 11.09% |
| 2017 | 234.24 Billion KRW | 0.19% |
| 2016 | 233.81 Billion KRW | -1.98% |
| 2015 | 238.53 Billion KRW | 13.52% |
| 2014 | 210.12 Billion KRW | 4.71% |
| 2013 | 200.68 Billion KRW | -9.81% |
| 2012 | 222.5 Billion KRW | 14.81% |
| 2011 | 193.8 Billion KRW | 57.08% |
| 2010 | 123.37 Billion KRW | 32.85% |
| 2009 | 92.87 Billion KRW | -5.76% |
| 2008 | 98.54 Billion KRW | 38.97% |
| 2007 | 70.91 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 433.43 Billion KRW | 1.0% |
| 2024 Q2 | 435.14 Billion KRW | 0.4% |
| 2023 FY | 429.14 Billion KRW | 16.72% |
| 2023 Q4 | 429.14 Billion KRW | -0.57% |
| 2023 Q1 | 393.74 Billion KRW | 7.1% |
| 2023 Q3 | 431.59 Billion KRW | 6.33% |
| 2023 Q2 | 405.89 Billion KRW | 3.08% |
| 2022 Q1 | 325.32 Billion KRW | 2.74% |
| 2022 FY | 367.65 Billion KRW | 16.1% |
| 2022 Q4 | 367.65 Billion KRW | 1.47% |
| 2022 Q3 | 362.31 Billion KRW | 4.34% |
| 2022 Q2 | 347.23 Billion KRW | 6.73% |
| 2021 FY | 316.66 Billion KRW | 2.03% |
| 2021 Q1 | 318.76 Billion KRW | 2.71% |
| 2021 Q3 | 327.16 Billion KRW | 6.0% |
| 2021 Q4 | 316.66 Billion KRW | -3.21% |
| 2021 Q2 | 308.63 Billion KRW | -3.18% |
| 2020 Q3 | 328.11 Billion KRW | 3.82% |
| 2020 Q2 | 316.03 Billion KRW | 4.53% |
| 2020 Q1 | 302.32 Billion KRW | 1.14% |
| 2020 FY | 310.35 Billion KRW | 3.83% |
| 2020 Q4 | 310.35 Billion KRW | -5.41% |
| 2019 Q4 | 298.91 Billion KRW | -3.3% |
| 2019 FY | 298.91 Billion KRW | 14.87% |
| 2019 Q3 | 309.1 Billion KRW | -4.82% |
| 2019 Q2 | 324.75 Billion KRW | 18.68% |
| 2019 Q1 | 273.63 Billion KRW | 5.16% |
| 2018 FY | 260.21 Billion KRW | 11.09% |
| 2018 Q1 | 247.25 Billion KRW | 5.55% |
| 2018 Q2 | 251.72 Billion KRW | 1.81% |
| 2018 Q3 | 257.13 Billion KRW | 2.15% |
| 2018 Q4 | 260.21 Billion KRW | 1.2% |
| 2017 Q1 | 233.49 Billion KRW | -0.14% |
| 2017 FY | 234.24 Billion KRW | 0.19% |
| 2017 Q4 | 234.24 Billion KRW | 0.73% |
| 2017 Q3 | 232.55 Billion KRW | -1.22% |
| 2017 Q2 | 235.43 Billion KRW | 0.83% |
| 2016 FY | 233.81 Billion KRW | -1.98% |
| 2016 Q4 | 233.81 Billion KRW | 5.96% |
| 2016 Q2 | 237.82 Billion KRW | 1.89% |
| 2016 Q3 | 220.66 Billion KRW | -7.21% |
| 2016 Q1 | 233.4 Billion KRW | -2.15% |
| 2015 Q3 | 239.14 Billion KRW | 1.48% |
| 2015 Q4 | 238.53 Billion KRW | -0.25% |
| 2015 FY | 238.53 Billion KRW | 13.52% |
| 2015 Q2 | 235.64 Billion KRW | 10.65% |
| 2015 Q1 | 212.96 Billion KRW | 1.35% |
| 2014 Q2 | 217.29 Billion KRW | 5.54% |
| 2014 Q1 | 205.89 Billion KRW | 2.59% |
| 2014 Q3 | 220.96 Billion KRW | 1.69% |
| 2014 FY | 210.12 Billion KRW | 4.71% |
| 2014 Q4 | 210.12 Billion KRW | -4.91% |
| 2013 FY | 200.68 Billion KRW | -9.81% |
| 2013 Q4 | 200.68 Billion KRW | -1.31% |
| 2013 Q3 | 203.35 Billion KRW | -17.13% |
| 2013 Q2 | 245.39 Billion KRW | 5.43% |
| 2013 Q1 | 232.76 Billion KRW | 4.61% |
| 2012 Q1 | 169.97 Billion KRW | 0.0% |
| 2012 Q4 | 222.5 Billion KRW | 0.0% |
| 2012 FY | 222.5 Billion KRW | 14.81% |
| 2011 FY | 193.8 Billion KRW | 57.08% |
| 2011 Q3 | 126.71 Billion KRW | 24.73% |
| 2011 Q2 | 101.59 Billion KRW | 16.58% |
| 2011 Q1 | 87.14 Billion KRW | 0.0% |
| 2010 Q1 | 39.07 Billion KRW | 0.0% |
| 2010 Q3 | 55.51 Billion KRW | 4.0% |
| 2010 FY | 123.37 Billion KRW | 32.85% |
| 2010 Q2 | 53.38 Billion KRW | 36.63% |
| 2009 FY | 92.87 Billion KRW | -5.76% |
| 2009 Q3 | 41.59 Billion KRW | 10.65% |
| 2009 Q2 | 37.59 Billion KRW | 8.45% |
| 2009 Q1 | 34.66 Billion KRW | 0.0% |
| 2008 Q1 | 49.26 Billion KRW | 0.0% |
| 2008 FY | 98.54 Billion KRW | 38.97% |
| 2008 Q2 | 30.18 Billion KRW | -38.72% |
| 2008 Q3 | 34.27 Billion KRW | 13.52% |
| 2007 Q3 | 33.76 Billion KRW | 0.21% |
| 2007 Q1 | 33.86 Billion KRW | 0.0% |
| 2007 FY | 70.91 Billion KRW | 0.0% |
| 2007 Q2 | 33.69 Billion KRW | -0.52% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 8.8 Billion KRW | -4775.432% |
| Dong-A Socio Holdings Co., Ltd. | 572.02 Billion KRW | 24.977% |
| Ildong Holdings Co., Ltd. | 310.87 Billion KRW | -38.046% |
| HANDOK Inc. | 283.45 Billion KRW | -51.399% |
| Kukje Pharma Co., Ltd. | 20.07 Billion KRW | -2038.023% |
| Yuhan Corporation | -69.18 Billion KRW | 720.277% |
| Dong-A ST Co., Ltd. | 193.95 Billion KRW | -121.267% |
| SAMSUNG PHARM. Co., LTD. | -3.68 Billion KRW | 11743.229% |
| Hanmi Pharm. Co., Ltd. | 517.88 Billion KRW | 17.135% |
| Hanall Biopharma Co.,Ltd | -32.43 Billion KRW | 1423.227% |
| Ilyang Pharmaceutical Co.,Ltd | 75.67 Billion KRW | -467.095% |
| Dong Sung Bio Pharm.Co.,Ltd. | 36.83 Billion KRW | -1064.98% |
| MYUNGMOON Pharm co.,Ltd | 82.52 Billion KRW | -420.052% |
| Hana Pharm Co., Ltd. | 25.1 Billion KRW | -1609.18% |
| Yuyu Pharma, Inc. | 8.8 Billion KRW | -4775.432% |
| Ilsung Pharmaceuticals Co., Ltd. | -159.84 Billion KRW | 368.474% |
| REYON Pharmaceutical Co., Ltd. | 200.94 Billion KRW | -113.563% |
| Aprogen pharmaceuticals,Inc. | 170.94 Billion KRW | -151.046% |
| JW Holdings Corporation | 480.68 Billion KRW | 10.722% |
| Ildong Pharmaceutical Co., Ltd. | 164.58 Billion KRW | -160.749% |
| Chong Kun Dang Pharmaceutical Corp. | 117.53 Million KRW | -365034.481% |
| JW Pharmaceutical Corporation | 154.37 Billion KRW | -177.997% |
| Shin Poong Pharm.Co.,Ltd. | 2.35 Billion KRW | -18151.368% |
| Hyundai Pharmaceutical Co., Ltd. | 23 Billion KRW | -1765.743% |
| Samil Pharmaceutical Co.,Ltd | 174.97 Billion KRW | -145.266% |
| Jeil Pharmaceutical Co.,Ltd | 51.97 Billion KRW | -725.687% |
| Yuyu Pharma, Inc. | 8.8 Billion KRW | -4775.432% |
| Kwang Dong Pharmaceutical Co., Ltd. | 158.29 Billion KRW | -171.103% |
| Daewoong pharmaceutical Co.,Ltd | 358.17 Billion KRW | -19.814% |
| JW Pharmaceutical Corporation | 154.37 Billion KRW | -177.997% |
| Yuhan Corporation | -69.18 Billion KRW | 720.277% |
| Jeil Pharma Holdings Inc | 135.99 Billion KRW | -215.569% |
| Yungjin Pharm. Co., Ltd. | 59.67 Billion KRW | -619.151% |
| JW Pharmaceutical Corporation | 154.37 Billion KRW | -177.997% |
| Samjin Pharmaceuticals Co., Ltd. | 116.23 Billion KRW | -269.202% |
| Korea United Pharm Inc. | 16.42 Billion KRW | -2512.755% |
| CKD Bio Corp. | 143.29 Billion KRW | -199.483% |
| Daewon Pharmaceutical Co., Ltd. | 116.06 Billion KRW | -269.741% |
| Dongwha Pharm.Co.,Ltd | -24.06 Billion KRW | 1883.53% |
| Whan In Pharm Co.,Ltd. | -44.73 Billion KRW | 1059.331% |
| Shin Poong Pharm.Co.,Ltd. | 2.35 Billion KRW | -18151.368% |
| Chong Kun Dang Holdings Corp. | 422.84 Billion KRW | -1.492% |
| Boryung Corporation | 187.72 Billion KRW | -128.601% |
| Bukwang Pharmaceutical Co., Ltd. | -71.84 Billion KRW | 697.365% |
| Ilyang Pharmaceutical Co.,Ltd | 75.67 Billion KRW | -467.095% |
| JW Lifescience Corporation | 26.09 Billion KRW | -1544.831% |